Herantis Pharma Oyj

Herantis Pharma Oyjverified

HRPMF

Price:

$3.51

Market Cap:

$50.94M

Herantis Pharma Oyj, a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to its developmental efforts is HER-096, a sophisticated, compact, synthetic chemical peptidomimetic originating from the active parent molecule. This preclinical xCDNF candidate is currently being investigated for its therapeutic promise in PD and other neurodegenerative conditions. Additionally, the firm is advancing recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is presently undergoing Phase I clinical evaluation in individuals afflicted with Parkinso...[Read more]

Industry

Biotechnology

IPO Date

2018-10-30

Stock Exchange

OTC

Ticker

HRPMF

The Enterprise Value as of June 2026 (TTM) for Herantis Pharma Oyj (HRPMF) is 53.64M

According to Herantis Pharma Oyj’s latest financial reports and current stock price. The company's current Enterprise Value is 53.64M. This represents a change of 49.23% compared to the average of 35.94M of the last 4 quarters.

Herantis Pharma Oyj (HRPMF) Historical Enterprise Value (quarterly & annually)

How has HRPMF Enterprise Value performed in the past?

The mean historical Enterprise Value of Herantis Pharma Oyj over the last ten years is 30.39M. The current 53.64M Enterprise Value has changed 17.55% with respect to the historical average. Over the past ten years (40 quarters), HRPMF's Enterprise Value was at its highest in in the December 2025 quarter at 51.85M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.

Quarterly (TTM)
Annual

Average

30.39M

Median

27.62M

Minimum

19.68M

Maximum

50.91M

Herantis Pharma Oyj (HRPMF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Herantis Pharma Oyj Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.48%

Maximum Annual Enterprise Value = 50.91M

Minimum Annual Increase = -47.66%

Minimum Annual Enterprise Value = 19.68M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202550.91M69.48%
202430.04M38.43%
202321.70M-8.38%
202223.68M0.56%
202123.55M-7.82%
202025.55M-47.66%
201948.82M61.36%
201830.26M1.89%
201729.69M50.91%
201619.68M65.46%

Herantis Pharma Oyj (HRPMF) Average Enterprise Value

How has HRPMF Enterprise Value performed in the past?

The current Enterprise Value of Herantis Pharma Oyj (HRPMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

34.22M

5-year avg

29.98M

10-year avg

30.39M

Herantis Pharma Oyj (HRPMF) Enterprise Value vs. Peers

How is HRPMF’s Enterprise Value compared to its peers?

Herantis Pharma Oyj’s Enterprise Value is less than Oncopeptides AB (publ) (327.81M), greater than Biostage, Inc. (18.74M), less than Mindset Pharma Inc. (66.42M), greater than Goodness Growth Holdings, Inc. (-35453904.00), less than Abliva AB (publ) (683.00M), greater than Karolinska Development AB (publ) (-29727500.00), greater than Elegance Optical International Holdings Limited (42.02M), less than Relief Therapeutics Holding AG (0), greater than Small Pharma Inc. (34.54M), less than SymBio Pharmaceuticals Limited (2.99B),

Build a custom stock screener for Herantis Pharma Oyj (HRPMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Herantis Pharma Oyj using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Herantis Pharma Oyj (HRPMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Herantis Pharma Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Herantis Pharma Oyj's Enterprise Value?

What is the highest Enterprise Value for Herantis Pharma Oyj (HRPMF)?

What is the 3-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?

What is the 5-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?

How does the current Enterprise Value for Herantis Pharma Oyj (HRPMF) compare to its historical average?